The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Telit Enables Mymemo, the Worlds' First and Only Modular Pill Dispenser, Designed to Meet Diverse Needs
Mohammad
i am watching you from above..
and it is gambling
Mohammad11 you should not be gambling
Haram!!
Telit Communications
Telit CAT-M modules receive Verizon certification
RNS Number : 0527R
Telit Communications PLC
25 June 2020
Telit Communications PLC
Telit expands global availability of CAT-M modules with certification by Verizon
London, June 25, 2020 - Telit Communications PLC ("Telit", "the Group", AIM: TCM), a global enabler of the Internet of Things (IoT), today announced that its CAT-M modules, the ME310G1 and ME910G1, have been certified for use on Verizon's 4G LTE network. The modules have now been certified - and can be deployed - by several major US networks, further expanding their availability on an international level.
Based on the Qualcomm 9205 LTE IoT modem, the modules are used for wearable medical devices, smart utility metering, industrial sensors, and other applications that require long battery life and reliable connectivity even deep inside buildings.
Key features of the ME310G1-W1 and ME910G1-W1 modules include Power Saving Mode (PSM) and extended Discontinuous Reception (eDRX) to maximize battery life, and a maximum coupling loss (MCL) of up to +15dB/+20dB to ensure reliable indoor connectivity.
For applications also targeted at markets outside the United States, the certified modules' different variants offer 2G fallback and extended coverage which allows IoT devices to operate in all network conditions, significantly reducing coverage issues. For devices deployed globally or across multiple countries, 2G fallback also ensures connectivity where more advanced networks are not yet deployed on a national scale.
Paolo Dal Pino, Chief Executive Officer, Telit, commented : "Receiving certification of our CAT-M modules by a major US network like Verizon allows us to address high levels of demand in the market for modules providing reliable connectivity with low power consumption. It is an important step in our efforts to achieve global availability for the CAT-M modules."
The coronavirus pandemic is "accelerating" and has reached "a new and dangerous phase", according to the World Health Organisation (WHO).
More than 150,000 new cases of the virus were reported to the global health agency on Thursday – the most in a single day so far – WHO chief Tedros Adhanom Ghebreyesus said at a press conference in Geneva on Friday.
"Almost half of those cases were reported from the Americas, with large numbers also being reported from South Asia and the Middle East," he said.
Tedros said the world had now entered "a new and dangerous phase" where most people were fed up with being at home.
De La Rue plc Ordinary 44 152/175p
Type:Open OfferShareholder action required:NoStatus:Effective date: 19th Jun 2020
Details (last updated 19 Jun 2020)
De La Rue plc has announced its intention to raise cash by way of an open offer.
The Open Offer will be available to all Shareholders as at close of business on 16 June 2020. If you hold Shares at this time you will be entitled to purchase 7 new Shares for every 16 Shares held, at a price of 110p per Share. Excess applications will also be allowed.
Entitlements to participate will be issued from Friday 19 June. You need take no action at present. We will write to Qualifying Shareholders confirming full terms of the Open Offer shortly after 19 June 2020, at which point an online election facility will be enabled for qualifying shareholders to give an instruction. Our deadline for the Open Offer is expected to be noon on Wednesday 1 July 2020.
F. Hoffmann-La Roche Ltd
Positive phase III results for Venclexta/Venclyxto combination in acute myeloid leukaemia presented at EHA 2020
Phase III VIALE-A study showed Venclexta/Venclyxto plus azacitidine helped people with the most common type of aggressive adult leukaemia live longer compared to azacitidine alone
Data will be presented as a late-breaking abstract at the 25th European Hematology Association Virtual Congress
Basel, 13 June 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced positive results from the phase III VIALE-A study, evaluating Venclexta®/Venclyxto® (venetoclax) in combination with azacitidine in people with previously untreated acute myeloid leukaemia (AML) who were ineligible for intensive induction chemotherapy. VIALE-A results were featured in the 25th European Hematology Association Virtual Congress Press Briefing on Saturday 13 June 2020 at 08:30 CEST and will be presented at the congress during the Late-breaking Oral Session (abstract #LB2601) on Sunday 14 June 2020.
“We are very pleased to present these important results from people with acute myeloid leukaemia, especially those who are unable to tolerate intensive chemotherapy and therefore have limited treatment options,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “The significant survival benefits observed in the VIALE-A study reinforce the potential utility of this Venclexta/Venclyxto-based combination for people with this aggressive disease.
Nuformix PLC - pharmaceutical development - Says GBP1.3 million equity fundraise from last year and low operating costs make it "well-placed" to cope with Covid-19 hurt. Notes it may miss out of a GBP2.5 million payment from Chinese partner Newsummit Biopharma, which has fallen out with its own parent company. Teams with New York-listed VistaGen Therapeutics to develop crystalline versions of the latter's central nervous system medication candidates.
Coronavirus 'disappearing' so fast Oxford vaccine has 'only 50% chance of working'
Professor Adrian Hill describes the efforts to create a vaccine as a "race against the virus disappearing, and against time".
Sunday 24 May 2020 15:49, UK
Telit LM960A18 mPCIe LTE Module Joins the United Kingdom's Emergency Services Network (ESN) Lineup
19/05/2020 2:00pm
PR Newswire (US)
Telit Communications (LSE:TCM)
Intraday Stock Chart
Wednesday 20 May 2020
Click Here for more Telit Communications Charts.
LONDON, May 19, 2020 /PRNewswire/ -- Telit, a global enabler of the Internet of Things (IoT), today announced that its LM960A18 PCI Express Mini Card (mPCIe) is the first Gigabit LTE module to go through the United Kingdom's Emergency Services Network (ESN) review for use by the ecosystem. Joining the ESN lineup is the latest milestone in Telit's commitment to providing the first responder community with solutions and support for potentially lifesaving applications. The LM960A18 is an IoT module that ESN original equipment manufacturers (OEMs), such as handheld devices and wireless routers, can use for gigabit cellular communications.
19/05/2020 5:30pm
PR Newswire (US)
Micro Focus (LSE:MCRO)
Intraday Stock Chart
Wednesday 20 May 2020
Click Here for more Micro Focus Charts.
SANTA CLARA, Calif., May 19, 2020 /PRNewswire/ -- Micro Focus (LSE: MCRO; NYSE: MFGP) today awarded the prestigious Digital Transformation Innovation Award to General Motors (GM) and the Carrefour Group, in recognition of their outstanding efforts leveraging technology in new and inventive ways to respond to emerging market demands, helping them to effectively run and transform their business. The awards will be announced this week at Micro Focus Universe 2020, the company's flagship customer event, being conducted virtually this year due to the current pandemic.